Dianthus Therapeutics, Inc. /DE/
Clinical-stage biotech developing therapies for severe autoimmune diseases.
DNTH | US
Overview
Corporate Details
- ISIN(s):
- US2528281080 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 7 TIMES SQUARE, 10036 NEW YORK
- Website:
- https://dianthustx.com/
Description
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company developing next-generation therapies for severe autoimmune diseases. The company engineers novel monoclonal antibodies with potentially best-in-class properties, focusing on proven mechanisms of action. Its lead candidate, claseprubart (DNTH103), is a potent and highly selective antibody targeting the active C1s complement protein. It is engineered with an extended half-life designed to allow for convenient, less frequent self-administered subcutaneous injections. The company's pipeline also includes DNTH212, a bifunctional inhibitor that targets Type 1 IFN suppression and B cell modulation. Dianthus aims to transform treatment for patients by developing therapies with the potential for improved clinical outcomes and greater convenience.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
|
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB
Full Filing History RestrictedAccess to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset. |
|||||
Automate Your Workflow. Get a real-time feed of all Dianthus Therapeutics, Inc. /DE/ filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Dianthus Therapeutics, Inc. /DE/
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Dianthus Therapeutics, Inc. /DE/ via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
